LISATA THERAPEUTICS, INC.: 10-Q filed 2017-08-10

Name: LISATA THERAPEUTICS, INC.: 10-Q filed 2017-08-10
Creator: LISATA THERAPEUTICS, INC.

What LISATA THERAPEUTICS, INC. reported in its quarterly report filed 2017-08-10 (fiscal Q2 2017): 35 published measures, 98 facts as tagged in accession 0000320017-17-000060.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-08-10
Fiscal period: fiscal Q2 2017
Accession: 0000320017-17-000060 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All LISATA THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-06-30	72,247,860	USD
At 2016-12-31	53,514,442	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-06-30	18,211,222	USD
At 2016-12-31	30,047,962	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-06-30	54,420,819	USD
At 2016-12-31	4,883,909	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2017-06-30	23,044,844	USD
At 2016-12-31	7,076,651	USD
At 2016-06-30	10,344,392	USD
At 2015-12-31	18,657,971	USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2017-01-01 to 2017-06-30	-15,577,122	USD	181
2016-01-01 to 2016-06-30	-14,575,555	USD	182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2017-01-01 to 2017-06-30	97,052	USD	181
2016-01-01 to 2016-06-30	1,068,129	USD	182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2017-01-01 to 2017-06-30	-2,912,357	USD	181
2016-01-01 to 2016-06-30	13,660,127	USD	182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2017-01-01 to 2017-06-30	26,829,315	USD	181
2016-01-01 to 2016-06-30	-1,703,297	USD	182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-06-30	-375,429,627	USD
At 2016-12-31	-404,788,809	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-5,887,543	USD	91
2017-01-01 to 2017-06-30	-5,887,543	USD	181
2016-04-01 to 2016-06-30	0	USD	91
2016-01-01 to 2016-06-30	0	USD	182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-06-30	432,853	USD
At 2016-12-31	705,439	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-7,710,317	USD	91
2017-01-01 to 2017-06-30	-14,142,843	USD	181
2016-04-01 to 2016-06-30	-7,405,824	USD	91
2016-01-01 to 2016-06-30	-18,282,095	USD	182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-06-30	70,412,544	USD
At 2016-12-31	24,648,961	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	204,484	USD	91
2017-01-01 to 2017-06-30	363,412	USD	181
2016-04-01 to 2016-06-30	335,884	USD	91
2016-01-01 to 2016-06-30	1,233,057	USD	182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-06-30	14,551,394	USD
At 2016-12-31	21,182,893	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2017-06-30	1,114,122	USD
At 2016-12-31	2,226,580	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2017-06-30	335,646	USD
At 2016-12-31	138,774	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	7,710,317	USD	91
2017-01-01 to 2017-06-30	14,142,843	USD	181
2016-04-01 to 2016-06-30	7,405,824	USD	91
2016-01-01 to 2016-06-30	18,282,095	USD	182

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	3,432,534	USD	91
2017-01-01 to 2017-06-30	6,138,928	USD	181
2016-04-01 to 2016-06-30	2,917,221	USD	91
2016-01-01 to 2016-06-30	7,744,643	USD	182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	4,277,783	USD	91
2017-01-01 to 2017-06-30	8,003,915	USD	181
2016-04-01 to 2016-06-30	4,488,603	USD	91
2016-01-01 to 2016-06-30	10,537,452	USD	182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-06-30	8,912,602	shares
At 2016-12-31	8,205,791	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-06-30	430,606,930	USD
At 2016-12-31	410,372,049	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2017-06-30	-57,860	USD
At 2016-12-31	0	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2017-06-30	54,036,638	USD
At 2016-12-31	4,066,480	USD
At 2016-06-30	5,636,628	USD
At 2015-12-31	23,283,824	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2017-06-30	1,402,463	USD
At 2016-12-31	1,582,209	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2017-06-30	3,636,538	USD
At 2016-12-31	389,858	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2017-06-30	12,408,604	USD
At 2016-12-31	2,659,433	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2017-06-30	5,706,396	USD
At 2016-12-31	1,900,493	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-7,909,973	USD	91
2017-01-01 to 2017-06-30	-14,545,822	USD	181
2016-04-01 to 2016-06-30	-7,732,951	USD	91
2016-01-01 to 2016-06-30	-19,500,710	USD	182

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	38,465,008	USD	91
2017-01-01 to 2017-06-30	28,671,684	USD	181
2016-04-01 to 2016-06-30	-7,884,770	USD	91
2016-01-01 to 2016-06-30	-19,932,566	USD	182

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	38,661,149	USD	91
2017-01-01 to 2017-06-30	29,301,322	USD	181
2016-04-01 to 2016-06-30	-7,835,202	USD	91
2016-01-01 to 2016-06-30	-19,816,119	USD	182

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	38,719,009	USD	91
2017-01-01 to 2017-06-30	29,359,182	USD	181
2016-04-01 to 2016-06-30	-7,834,716	USD	91
2016-01-01 to 2016-06-30	-19,815,633	USD	182

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	4,828	USD	91
2017-01-01 to 2017-06-30	-39,567	USD	181
2016-04-01 to 2016-06-30	8,757	USD	91
2016-01-01 to 2016-06-30	14,442	USD	182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2017-04-01 to 2017-06-30	-199,656	USD	91
2017-01-01 to 2017-06-30	-402,979	USD	181
2016-04-01 to 2016-06-30	-327,127	USD	91
2016-01-01 to 2016-06-30	-1,218,615	USD	182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-06-30	196,872	USD	181
2016-01-01 to 2016-06-30	97,904	USD	182

Inspect the source

Entity: LISATA THERAPEUTICS, INC. / CIK 0000320017
Captured: 2026-09-19T14:56:51.274Z
SEC response SHA-256: cea21c045f03a86f28b8ca2c2ed8647182755ec7b9afe40200702f5307c095db

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000320017.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))